AKT1 and metabolic dysfunction-associated steatotic liver disease: In this study, in the PM2.5-induced NAFLD model, TF regulating the IRs-1/Akt pathway produced pharmaceutical effects on excessive lipids accumulation (including TC, TG, HDL, and LDL), which was associated with IR.